Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.
Hu Z, Pan XF, Wu FQ, Ma LY, Liu DP, Liu Y, Feng TT, Meng FY, Liu XL, Jiang QL, Chen XQ, Liu JL, Liu P, Chen Z, Chen SJ, Zhou GB.
Hu Z, et al. Among authors: ma ly.
PLoS One. 2009 Jul 16;4(7):e6257. doi: 10.1371/journal.pone.0006257.
PLoS One. 2009.
PMID: 19606213
Free PMC article.